KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Depreciation & Amortization (CF) (2018 - 2025)

LifeMD (LFMD) has disclosed Depreciation & Amortization (CF) for 10 consecutive years, with $256431.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 77.7% year-over-year to $256431.0, compared with a TTM value of $3.2 million through Dec 2025, up 3.99%, and an annual FY2025 reading of $866000.0, down 86.03% over the prior year.
  • Depreciation & Amortization (CF) was $256431.0 for Q4 2025 at LifeMD, down from $262747.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.7 million in Q1 2025 and bottomed at $10695.0 in Q4 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $393608.5, with a median of $57666.0 recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (CF) soared 2974.84% in 2024, then tumbled 33.33% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $10695.0 in 2021, then surged by 319.61% to $44877.0 in 2022, then increased by 28.5% to $57666.0 in 2023, then skyrocketed by 150.24% to $144302.0 in 2024, then soared by 77.7% to $256431.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for LFMD at $256431.0 in Q4 2025, $262747.0 in Q3 2025, and $1.0 million in Q2 2025.